Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-25-011543
Filing Date
2025-06-12
Accepted
2025-06-12 16:28:45
Documents
2
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3a.html 3/A  
1 AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3a.xml 3/A 3950
2 POA exhibit24-1.txt EX-24.1 3476
  Complete submission text file 0001062993-25-011543.txt   8973
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 167 CARMELA COURT JUPITER FL 33478
Business Address
Chandrasekhar Satishchandran (Reporting) CIK: 0001832285 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36751 | Film No.: 251043178